GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $75,000 | 0.0% | 1,724 | 0.0% | 0.05% | +13.3% |
| Q1 2022 | $75,000 | -1.3% | 1,724 | 0.0% | 0.04% | -2.2% |
| Q4 2021 | $76,000 | +15.2% | 1,724 | 0.0% | 0.05% | +4.5% |
| Q3 2021 | $66,000 | -4.3% | 1,724 | 0.0% | 0.04% | -6.4% |
| Q2 2021 | $69,000 | +11.3% | 1,724 | 0.0% | 0.05% | 0.0% |
| Q1 2021 | $62,000 | -3.1% | 1,724 | 0.0% | 0.05% | -14.5% |
| Q4 2020 | $64,000 | -9.9% | 1,724 | -8.7% | 0.06% | -19.1% |
| Q3 2020 | $71,000 | -38.8% | 1,888 | -33.6% | 0.07% | -45.6% |
| Q2 2020 | $116,000 | +7.4% | 2,845 | 0.0% | 0.12% | -8.1% |
| Q1 2020 | $108,000 | -19.4% | 2,845 | 0.0% | 0.14% | +2.3% |
| Q4 2019 | $134,000 | +13.6% | 2,845 | 0.0% | 0.13% | +17.7% |
| Q3 2019 | $118,000 | +0.9% | 2,845 | 0.0% | 0.11% | +2.7% |
| Q2 2019 | $117,000 | -29.9% | 2,845 | -28.7% | 0.11% | -31.2% |
| Q1 2019 | $167,000 | +6.4% | 3,992 | 0.0% | 0.16% | +4.6% |
| Q4 2018 | $157,000 | – | 3,992 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
| Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
| Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
| Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
| Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
| Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
| NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
| Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
| SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
| Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |